Browse the evidence

Methanobrevibacter (archaea) and Candida (fungi) show positive covariation with bacterial genera Prevotella and Ruminococcus, suggesting a syntrophic guild centered on carbohydrate fermentation.

Your gut ecosystem includes interactions between bacteria, fungi, and archaea. High-carb diets tend to bring these groups (Prevotella, Ruminococcus, Candida, Methanobrevibacter) together in a functional guild that processes carbohydrates.

Gut microbiome composition has little to no significant effect on LDL cholesterol or Total Cholesterol levels.

Focusing on gut health may not be the primary strategy for lowering LDL cholesterol. While it may help with triglycerides and HDL, LDL levels appear largely independent of microbiome composition in this study.

Classification of dietary fiber by water solubility is an unreliable predictor of physiological effects, as solubility does not directly correlate with fermentability or short-chain fatty acid (SCFA) profiles.

Do not choose foods based on whether they are 'soluble' or 'insoluble' fiber. This classification is scientifically flawed for predicting health benefits. Instead, eat a variety of fiber-rich whole foods (vegetables, fruits, whole grains, legumes) to ensure you get a mix of physiological effects.

High-molecular-weight polysaccharides (>300 kDa) from Hirsutella sinensis mycelium reduce diet-induced obesity and metabolic disorders in mice by selectively enriching the gut bacterium Parabacteroides goldsteinii.

This research suggests that consuming high-molecular-weight polysaccharides from Hirsutella sinensis (a medicinal fungus) may help manage weight and metabolic health by feeding beneficial gut bacteria, specifically Parabacteroides goldsteinii. In mice, this led to a 50% reduction in weight gain on a high-fat diet. While promising, this is an animal study. For humans, this implies that prebiotic fibers that support specific gut bacteria might be beneficial for metabolic health, but direct supplementation with this specific fungal fraction is not yet a standard human treatment.

Oral administration of live Parabacteroides goldsteinii reduces obesity, improves insulin sensitivity, and enhances thermogenesis in high-fat diet-fed mice.

This study suggests that Parabacteroides goldsteinii is a beneficial gut bacterium that can help reduce obesity and improve metabolic health. While you cannot currently buy this specific strain as a commercial probiotic supplement, the findings highlight the importance of supporting beneficial gut bacteria through diet (prebiotics) to potentially improve metabolic health.

Long sleep duration is NOT significantly associated with incident hypertension, and evidence for depression and dyslipidemia is insufficient.

Do not assume that sleeping long hours will cause high blood pressure. This study found no significant link between long sleep and hypertension, unlike its links to heart disease and mortality.

There is a linear, dose-response relationship between longer sleep duration and increased mortality risk, with significant risk increasing at sleep durations >9.5 hours.

Your risk of mortality increases linearly as you sleep more. The data suggests significant risk begins to appear when you sleep more than 9.5 hours. Sticking to 7-9 hours minimizes this specific risk.

Biological aging is driven by the interaction between accumulated cellular damage and the decline of homeostatic resilience mechanisms, rather than chronological time alone.

Focus on maintaining healthspan by understanding that aging is not just a clock ticking but a biological process influenced by damage and repair. While no specific protocol is given, the implication is that interventions targeting the hallmarks of aging (like inflammation, mitochondrial function, or senescence) may slow biological aging.

Cellular senescence and the accumulation of senescent cells contribute to tissue degeneration and age-related diseases, making their removal or suppression a potential therapeutic target.

Understanding senescence highlights the importance of maintaining tissue health and potentially targeting senescent cells in the future. Current research focuses on quantifying senescence burden in humans.

Aging is characterized by a conserved transcriptional signature across mammals involving the upregulation of inflammatory and immune response genes (e.g., APOD, CTSS) and the downregulation of mitochondrial and collagen-related genes.

This research identifies specific gene expression patterns (increased inflammation/immune activity, decreased mitochondrial/collagen function) that are consistent hallmarks of aging across species. While this paper does not prescribe an intervention, it highlights that aging involves active biological responses (like inflammation) rather than just passive wear-and-tear. Future interventions targeting these specific pathways (e.g., anti-inflammatories or mitochondrial support) may be more effective than generic approaches.

In elderly women, the association between grip strength and mortality is not statistically significant after adjusting for confounding factors and body composition.

For elderly women, grip strength alone may not be a reliable standalone predictor of mortality risk after accounting for other health factors. The predictive power seen in men was not replicated in this female cohort, likely due to sample size.

Obesity prevalence in Europe has reached epidemic proportions, with significant geographic variation showing higher rates in Central, Eastern, and Southern Europe compared to Western and Northern Europe.

Obesity is a widespread and serious medical disorder in Europe, not just a cosmetic issue. Rates vary by region, with Southern and Eastern Europe facing higher burdens. Public health strategies must prioritize effective therapeutic and preventive measures tailored to these geographic disparities.

Dual energy X-ray absorptiometry (DXA) is the recommended reference standard for measuring muscle mass in clinical practice and research due to its balance of feasibility, accuracy, safety, and cost.

If you need to measure your muscle mass accurately, ask for a DXA scan. It is the current best balance of accuracy, safety, and cost. While other methods like BIA scales exist, they are less accurate for individuals. CT and MRI are too expensive and expose you to more radiation (CT) or are less available.

Industry-funded studies often report null findings regarding the adverse effects of sugar, potentially due to methodological limitations such as the use of milk as a vehicle, suboptimal statistical analysis, and lack of objective compliance monitoring.

Be skeptical of studies on sugar funded by the sugar industry. Look for independent research with robust methodologies, such as energy-balanced designs and objective compliance measures, to understand the true effects of sugar.

A high-fat, Western-style diet (HFD) causes systemic low-grade inflammation through gut dysbiosis, increased intestinal permeability (leaky gut), and subsequent translocation of lipopolysaccharide (LPS) into the bloodstream, which activates the TLR4/NF-κB inflammatory pathway.

Your diet directly shapes your gut bacteria. A diet high in fats, especially saturated and omega-6 fats, can damage your gut lining, allowing toxins (LPS) to enter your blood and trigger chronic inflammation. To protect your gut barrier, focus on reducing processed fats and increasing fiber-rich foods that support beneficial bacteria.

High levels of foreign direct investment (FDI) and free-trade agreements with high-income countries drive increased consumption of unhealthy commodities (soft drinks, processed foods, tobacco, alcohol) in low- and middle-income countries (LMICs), independent of economic growth.

For policymakers in LMICs: Do not assume economic growth will automatically lead to better health or that unhealthy consumption is inevitable. Prioritize regulations on foreign direct investment and free-trade agreements. Restricting market access for multinational unhealthy commodity producers can prevent the rise of NCDs, even as the economy grows. Focus on domestic food system resilience rather than open markets for processed foods.

In older adults (over ~80 years), maintaining a gut microbiome that becomes increasingly unique (divergent from common profiles) and depletes core genera like Bacteroides is a marker of healthy ageing and predicts higher survival rates.

For older adults, the composition of your gut microbiome matters more than just its diversity. Research suggests that as you age, your microbiome naturally becomes more unique to you. This 'drift' away from common bacterial profiles (specifically a decrease in Bacteroides) is linked to better health and survival. Instead of focusing solely on boosting common bacteria, focus on a varied diet that supports a unique microbial ecosystem, as indicated by the production of specific amino acid derivatives in the blood.

Long-term calorie restriction (CR) prevents age-related large artery stiffening and endothelial dysfunction by reducing oxidative stress and inflammation.

To improve vascular health and slow aging, consider reducing your daily caloric intake by 25% while ensuring you get all necessary nutrients. This approach, validated by the CALERIE trial, has been shown to reduce cardiovascular risk factors and slow biological aging in nonobese adults.

Pericardial fat is specifically associated with myocardial infarction and coronary heart disease, suggesting a local paracrine effect on coronary arteries, whereas VAT is more strongly associated with stroke, suggesting a systemic effect.

Targeting specific fat depots may offer targeted cardiovascular protection. Reducing visceral abdominal fat through diet and exercise can lower stroke risk, while managing overall adiposity may help reduce pericardial fat, potentially lowering the risk of myocardial infarction. A holistic approach to metabolic health addresses both systemic and local inflammatory risks.

The DunedinPoAm DNA methylation algorithm accurately quantifies the pace of biological aging (rate of decline in system integrity) rather than just chronological age, serving as a valid surrogate endpoint for testing interventions that slow aging.

This paper introduces a blood test (DunedinPoAm) that measures how fast your body is aging biologically, distinct from your chronological age. It is currently a research tool used to validate interventions like caloric restriction (CALERIE trial) that slow aging. For now, it is not a commercial consumer product, but it validates that slowing biological aging is measurable and that interventions like calorie restriction can impact this rate.

Genetic predisposition for longer habitual sleep duration is causally linked to an increased risk of schizophrenia, and conversely, genetic risk for schizophrenia causes longer sleep duration, indicating a bidirectional causal relationship.

If you naturally sleep longer than average (e.g., >8-9 hours), it may be partly due to your genetics. This paper suggests a causal link between longer sleep and higher schizophrenia risk, but also that schizophrenia risk drives longer sleep. Focus on overall mental health monitoring rather than trying to force shorter sleep, as sleep duration is largely genetically fixed.

Initiating supplemental parenteral nutrition (SPN) within the first week of ICU admission provides no clinically important benefit compared to enteral nutrition (EN) alone.

Do not start supplemental parenteral nutrition (SPN) in the first week of ICU stay for average critically ill patients. Focus on enteral nutrition (EN) tolerance. Consider SPN only after day 7 if EN remains insufficient, especially for malnourished patients.

Providing similar energy intake via parenteral nutrition (PN) as compared to enteral nutrition (EN) in the first week of critical illness results in similar clinical outcomes.

If a critically ill patient cannot tolerate enteral nutrition (EN), parenteral nutrition (PN) is an acceptable alternative. Ensure similar energy intake and monitor for glycemic control and catheter-related infections. Cost and convenience may guide the choice.

Dietary intake of choline (from phosphatidylcholine/egg yolk) and L-carnitine (from red meat) is metabolized by gut microbiota into trimethylamine (TMA), which is converted by hepatic FMO3 into TMAO, a metabolite that promotes atherosclerosis and increases cardiovascular disease risk.

High intake of red meat (L-carnitine) and egg yolks (choline/phosphatidylcholine) is linked to higher cardiovascular risk through a gut-liver metabolic pathway producing TMAO. While choline is essential, individuals with high cardiovascular risk may benefit from moderating intake of these specific precursors or discussing microbiome-targeted strategies with their provider, rather than relying solely on statins.